4//SEC Filing
Versant Venture Capital V, L.P. 4
Accession 0001567619-18-003538
CIK 0001656634other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:28 PM ET
Size
16.9 KB
Accession
0001567619-18-003538
Insider Transaction Report
Form 4
Transactions
- Conversion
Series B Convertible Preferred Stock
2018-10-02−929,020→ 0 total(indirect: See Footnote)→ Common Stock (929,020 underlying) - Conversion
Series A Convertible Preferred Stock
2018-10-02−2,173,909→ 0 total(indirect: See Footnote)→ Common Stock (2,173,909 underlying) - Conversion
Common Stock
2018-10-02+3,102,929→ 3,102,929 total(indirect: See Footnote)
Versant Venture Capital V, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-10-02+3,102,929→ 3,102,929 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2018-10-02−2,173,909→ 0 total(indirect: See Footnote)→ Common Stock (2,173,909 underlying) - Conversion
Series B Convertible Preferred Stock
2018-10-02−929,020→ 0 total(indirect: See Footnote)→ Common Stock (929,020 underlying)
Transactions
- Conversion
Series B Convertible Preferred Stock
2018-10-02−929,020→ 0 total(indirect: See Footnote)→ Common Stock (929,020 underlying) - Conversion
Common Stock
2018-10-02+3,102,929→ 3,102,929 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2018-10-02−2,173,909→ 0 total(indirect: See Footnote)→ Common Stock (2,173,909 underlying)
Transactions
- Conversion
Common Stock
2018-10-02+3,102,929→ 3,102,929 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2018-10-02−2,173,909→ 0 total(indirect: See Footnote)→ Common Stock (2,173,909 underlying) - Conversion
Series B Convertible Preferred Stock
2018-10-02−929,020→ 0 total(indirect: See Footnote)→ Common Stock (929,020 underlying)
Footnotes (5)
- [F1]The Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F2]The Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F3]Consists of (I) 2,723,031 shares held by Versant Venture Capital V, L.P. ("VVC V"), (ii) 207,234 shares held by Versant Venture Capital V (Canada) LP ("VVC CAN"), (iii) 90.756 shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), and (iv) 81,908 shares held by Versant Affiliates Fund V, L.P. ("VAF V"). Versant Ventures V, LLC, or VV V, serves as the sole general partner of VOA, VAF V and VVC V and owns no shares directly. Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP"), serves as the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which serves as the sole general partner of VVC CAN and owns no shares directly.
- [F4]Consists of (I) 1,907,729 shares held by Versant Venture Capital V, L.P. ("VVC V"), (ii) 145,186 shares held by Versant Venture Capital V (Canada) LP ("VVC CAN"), (iii) 63,610 shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), and (iv) 57,384 shares held by Versant Affiliates Fund V, L.P. ("VAF V"). Versant Ventures V, LLC, or VV V, serves as the sole general partner of VOA, VAF V and VVC V and owns no shares directly. Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP"), serves as the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which serves as the sole general partner of VVC CAN and owns no shares directly.
- [F5]Consists of (I) 815,302 shares held by Versant Venture Capital V, L.P. ("VVC V"), (ii) 62,048 shares held by Versant Venture Capital V (Canada) LP ("VVC CAN"), (iii) 27,146 shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), and (iv) 24,524 shares held by Versant Affiliates Fund V, L.P. ("VAF V"). Versant Ventures V, LLC, or VV V, serves as the sole general partner of VOA, VAF V and VVC V and owns no shares directly. Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP"), serves as the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which serves as the sole general partner of VVC CAN and owns no shares directly.
Documents
Issuer
Gritstone Oncology, Inc.
CIK 0001656634
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001589097
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:28 PM ET
- Size
- 16.9 KB